Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Compare 6-month and 12-month emergency funds to determine the best target for your finances, weighing liquidity, security, and timelines.
24,819 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investors are weighing CoreWeave against top AI stocks. This guide explains the risks, introduces three solid alterna...
Chord Energy reports strong 2025 results driven by Williston Basin efficiency, but investors question whether this wi...
Applied Optoelectronics shares climbed after a strong quarterly showing and renewed appetite for laser transceivers f...
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
A joint regulatory move reclassifies crypto assets into five categories, easing KYC-heavy requirements for developers...
U.S. policymakers confront a volatile oil backdrop and rising pump prices, weighing reserves, production, and demand ...
Ukraine expands its drone-defense footprint in the Middle East, signaling a broader role for Kyiv as global markets w...
The post-IPO market is buzzing about Swarmer, but excitement can blur judgment. Here are three practical realities ev...
Arizona lawmakers move two bills designed to curb local HOA and contractor licensing mandates, aiming to lower costs ...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
Cursor, valued near $29 billion, stands at the center of a fast-moving AI coding boom. The company faces intense grow...